Open access peer-reviewed chapter

Mesenchymal Stem Cell in the Intervertebral Disc

Written By

Dan Long, Shaoyu Liang, Haiyan Liu, Xiuping Wu, Zhongyang Li, Haozhong Wang, Shishu Huang and Jiancheng Zeng

Submitted: 04 January 2017 Reviewed: 18 April 2017 Published: 29 November 2017

DOI: 10.5772/intechopen.69296

From the Edited Volume

Mesenchymal Stem Cells - Isolation, Characterization and Applications

Edited by Phuc Van Pham

Chapter metrics overview

1,389 Chapter Downloads

View Full Metrics


Degeneration of the intervertebral disc (IVD) is a major spinal disorder that causes back pain. Nucleus pulposus (NP) in the central of IVD dehydrates and become more fibrous in the IVD degeneration. NP cells undergo apoptosis with the degeneration of extracellular matrix (ECM) components. To replenish the NP cells and core ECM, bone marrow mesenchymal stromal cells (BMSCs) have been highlighted in the regeneration of IVD degeneration. BMSCs differentiate into NP-like cells with the secretion of ECM components, which may not only replenish the number of NP cells but also stimulate NP reconstruction. This further maintains tissue homeostasis. Up to date, the disc progenitor cells (DPCs) have been identified with the characteristics of multidifferentiation and stem cell phenotype. These cells are involved in the IVD diseases and show regenerative potentials. However, the differences between the BMSCs and DPCs remain elusive, in particular, the cellular connection in vivo. As such, this chapter will discuss the findings of the two cell types and propose a novel concept in the understanding of the biology of IVD.


  • low back pain
  • intervertebral disc
  • nucleus pulposus
  • progenitor cells
  • extracellular matrix

1. Introduction

Low back pain (LBP) is the second most common symptom in the United States. Of the US population, 85% people experience an episode of LBP at some point in their lifetime. For individuals under 45 years, LBP remains the most common cause of disability and is generally associated with a work-related injury. In 2005, an estimate of 85.9 billion dollars was spent in the related treatment of back and neck pain. The relevant statistics indicated that the healthcare expenditures increased 65% between 1997 and 2005 without evidence of improvement in health status.


2. The shielded structure and rigid environment of intervertebral disc

An intervertebral disc (IVD) is a cylindrical structure, comprising a well-hydrated central nucleus pulposus (NP), an annulus fibrosus (AF) consisting of firm and flexible collagenous lamellae which surrounds the NP, and cartilaginous endplates forming an interface between the disc and adjacent vertebrae (Figure 1).

Figure 1.

Schematic cross-section of an intervertebral disc.

During the development of mammals, the vertebral column derives from the aggregation of mesenchymal cells around the notochord [1]. Following segmentation, motion segments emerge with large number of cells accumulating in the developing AF but fewer cells in the rapidly growing vertebral bodies. The cells in the AF become highly orientated, laying down the disc matrix in a similar orientation to form the concentric annular lamellar structure [1, 2]. Notochordal cells are named by their typical morphology of the notochord (physaliferous), a population of large cells with small and densely packed nuclei and cytoplasmic matrix vacuoles in human nucleus pulposus, are presumed remnants of the embryonic notochord that guided formation of the spine and the nuclei polposi [1]. The abundance of notochordal cells within NP declines with age at a rapid rate which varies among different species; where, by early adulthood in the human and species including that of chondrodystrophoid dog, nucleus becomes repopulated by chondrocyte-like cells that are thought to be originated from the adjacent endplate or inner AF regions [3]. All the previous results are solely based on the morphological detection and the existence of notochordal cells is believed to be significantly associated with aging. However, a recent study shows notochordal cells exist in human young and middle age by immunohistochemistry of notochordal cell markers. The occurrence of notochordal cells with immunohistochemical phenotype significantly correlates with granular matrix changes and cleft formation in the nucleus pulposus [4].

A network of microscopic blood vessels penetrates the endplates to principally provide nutrition for the disc and normally disappears around the time of skeletal maturity [3]. With a sparse vascular supply in the outer lamellae of the annulus, mature discs are totally reliant on diffusion of essential solutes across the endplates for nutrition and metabolic exchange [5]. The inner part of the IVD, particularly the NP, is completely avascular and aneural in the largest of the mature human lumbar IVD, where some cells can be 20 mm away from the nearest direct blood supply thereby making the NP severely hypoxic [5]. Mature IVD is composed of heterogeneous cell populations. A majority of the AF cells originate from the mesenchyme and exhibit many characteristics of fibroblasts and chondrocytes, such as the ability to synthesize the type I and II collagen and aggregating proteoglycans [3]. The morphology of AF cells may reflect their adaptation within the special biochemical and structural environment, as these cells appear ellipsoidal and align with the oriented collagen fibers within the lamellas [6]. Cells in the outer AF region display thin cytoplasmic projections that stain positive for both actin microfilaments and vimentin intermediate filaments, which have been associated with tissue regions subjected to compression [7]. Cells within the inner AF regions are often rounded, sparsely distributed, and surrounded by a pericellular matrix region rich in types III and VI collagen [7]. The NP is a gelatinous structure comprised primarily of aggrecan and type II collagen together with the small amounts of collagen type VI, IX, and XI. Cells are sparsely distributed in the NP and may also extend small cytoplasmic processes and, similar to chondrocytes, these cells highly express vimentin intermediate filaments, F-actin, and cytokeratins [7].

The most prominent feature of the IVD is its high content of extracellular matrix (ECM), which is substantially maintained by the cells within IVD, of which, the disc matrix is an elaborate structure of macromolecules that attract and hold water. The major structural components of the macromolecule are collagens and proteoglycans [8]. It is estimated that the ratio of type II collagen and the proteoglycan aggrecan in the AF is 1:20 [9]. Collagens provide firm and tensile strength whereas proteoglycans, through interactions with water, give the tissues stiffness, viscoelasticity and resistance to compression [8, 9]. Collagenous proteins comprise 70% of the outer annulus dry weight, but only account for 20% of NP [8, 9]. On the contrary, NP has a higher proteoglycan concentration, with up to 50% of the nucleus dry weight in adolescence. Given the co-existence of multiple matrix components and their high contents in IVD, the integrity of the IVD partially relies on the proper balance between the matrix synthesis and degradation, and the failure of which is suggested being a cause of the disc degeneration [9].

IVD degeneration is associated with the LBP. The IVD, especially the inner fibrosus (IF) and nucleus pulposus (NP), is virtually avascular and therefore highly hypoxic. At the cranial and caudal ends of each disc are the cartilaginous endplates that separate the vertebral bone from the disc itself and are believed to be the major channel of nutrient diffusion in IVD. Recent studies have reported changes in tissue structure, various cellular parameters and composition of matrix macromolecules in degenerated discs. Disc degeneration is characterized by decreased water and proteoglycan content and loss of the gel-like appearance of NP. Disc degeneration is thought to be contributed by increased cell senescence and dysregulated cellular activities. The IVD has limited nutrient, oxygen supply, and constant high mechanical stress. These may lead to difficulty for IVD to regenerate itself in IVD degeneration and injuries.


3. The finding of disc progenitor cells

Adult tissue-specific stem cells are a rare heterogeneous population of multipotent cells that can be isolated from many different adult and fetal tissues, including bone marrow, muscle, fat, hair follicles, tooth root, placenta, dermis, perichondrium, articular cartilage, umbilical cord, lung, and liver [10]. These cells show extensive proliferation, produce differentiated progeny, and functionally repair damaged tissues [11]. Adult stem cells normally reside in a specific cellular microenvironment (niche) that constitutes a privileged setting for the support of self-renewal [12]. There are three general properties unique for all the stem cells, regardless of their source. Clonogenicity, the ability of a single cell to proliferate independently to form a colony, is a property commonly ascribed to stem cells, although many clonogenic cells are limited in their capacity for expansion ex vivo [13]. Secondly, stem cells can give rise to specialized cells. When unspecialized stem cells give rise to specialized cells, the process is called differentiation [13]. Differentiation is triggered by the signals inside and outside cells. The internal signals from genes are interspersed across long strands of DNA and carry coded instructions for all cellular structures and functions [13]. The external signals comprise physical contact with neighboring cells, chemicals secreted by other cells, and certain molecules in the microenvironment [14]. The interaction of signals during differentiation causes the cell’s DNA to acquire epigenetic marks that restrict DNA expression in the cell and can be passed on through cell division [14]. Most adult stem cells are multipotent, capable of differentiating into at least three lineages (osteogenic, chondrogenic, and adipogenic) when cultured under defined in vitro conditions [14]. Thirdly, adult stem cells can go through numerous cycles of cell division while maintaining the undifferentiated state [15]. Stem cells are capable of dividing and renewing themselves for long periods. Unlike terminal stage cells, which do not normally replicate themselves, stem cells may replicate many times or proliferate. A starting population of stem cells that proliferates for many months in the laboratory can yield millions of cells [16]. If the resulting cells continue to be undifferentiated, like the original stem cells, the cells are said to be capable of self-renewal.

Bone marrow mesenchymal stromal cells (BMSCs) are composed of heterogeneous population of undifferentiated and committed cells [17]. The regenerative properties ascribed to BMSCs are characterized into three aspects: the plasticity to differentiate toward target cell types, the activation of the proliferation of resident cells, and the improvement of nutrient supply via paracrine effects. One of the remarkable phenomena of IVD degeneration is a reduction of proteoglycan content, partially caused by the apoptosis/necrosis of the nucleus pulposus (NP) cells in the IVD. The biotherapeutic treatment, therefore, aims to replenish the local resident cells and structural extracellular matrix (ECM) within IVD [18, 19]. Three-dimensional (3D) cultures have been used to induce BMSCs to differentiate into chondrocyte-like cells. These include cell pellet, alginate bead, hydrogel, and engineered 3D scaffold [2024]. Chondrocyte-like phenotype can also be obtained via a single monolayer co-culture of BMSCs, either with NPC or annulus fibrosis (AF) cells with cell-cell contact [25, 26]. Importantly, the chondrocyte-like cells have been shown to possess NPC phenotype [27, 28]. Via intradiscal injection into degenerative IVD, BMSCs are able to survive and commence proliferation under severe hypoxic environment [2932]. The production of ECM elevates in the NP post-transplantation, including aggrecan, collagen type, and glycosaminoglycans [33]. Animal studies have validated the effect of BMSCs. BMSCs are capable of replenishing NPCs and evoking their production of ECM components. This arrests the progressive decrease of disc height, as well as to partially maintain or even restore minimal disc height in mildly degenerative IVD [34]. Therefore, intradiscal transplantation of BMSCs shed some light on the maintenance of IVD homeostasis. However, the utility of BMSCs is still a subject of debate due to many unanswered questions. The method of transplantation, the choice of carrier, and the fate of BMSCs after delivery need further investigation. Notably, the intradiscal-delivered BMSCs have been found to leak from IVD and generate osteophytes [35]. Although embedding BMSCs in tissue-engineered scaffold before transplantation can alleviate the leakage issue, safety issues remain a concern [36].

IVD cannot self-repair and no cure is currently available for IVD degeneration. Various animal models have suggested the promising potential of mesenchymal stem cell (MSC) implantation to arrest IVD degeneration or even partially regenerate the disc [21, 37]. However, there are two major issues in MSC therapies: first, most studies are focused on the exogenous stem cells but the limitation is their potential immunogenicity. MSCs have indeed been shown to halt degeneration processes but are rarely able to completely regenerate the degenerative disc as the disc degeneration often continues after a certain period [37]. Besides, the therapy is invasive and therefore may potentially lead to complications such as infection and discitis. Second, all studies are carried out in quadruped animals and these models do not more closely resemble humans in terms of biomechanical loading in the spine, diffusion distances for nutrients and metabolites to the NP, age-related declination of notochordal cells, and the occurrence of age-related disc degeneration. In addition, most studies have been monitored only for relatively short time, in the range of weeks after treatments and their efficacy in long term remains elusive.

Recently, several studies have reported that cells derived from IVD tissue have multi-differentiation potential and possess mesenchymal stem cell-like features in vitro. NPCs express many MSC surface markers and are potent in differentiating into chondrogenic, osteogenic, and to some extent adipogenetic lineages [38, 39]. Similar multipotency of annulus fibrosus cells (AFCs) from scoliotic IVD was confirmed [40]. In degenerated and nondegenerated (scoliosis) IVD tissues, cells express stem/progenitor markers such as OCT3/4, CD105, CD90, STRO-1 and NOTCH1 [41]. A population of NPCs from nonchondrodystrophic canine IVD possesses neurogenic differentiation potential in vivo and expresses stemness genes, including Sox2, Oct3/4, Nanog, CD133, Nestin and NCAM [42]. Interestingly, this subset of NPCs expresses higher level of Nanog gene compared to BMSCs and is negative in the expression of protein 0 and Brachyury gene, which are positive in unsorted NPCs [42]. However, these data were drawn from models of mice, rats, dogs, rabbits, and even Chinese hamsters [43]. Differences between the IVDs of human and these animals, however, are large and present at multiple levels. These include anatomical structure, cellular and biochemical components, mechanical loading, and age-related changes. Nonhuman primates are closely related to humans and have been shown to be excellent model organisms for many health and disease conditions in human. The structure of the spine of the primates, including baboon and the higher species Rhesus monkeys, is similar to that of human, except with some deviations in the number of the vertebra and the spine curvature. The monkeys spend much of their time in semi-erect and erect positions, possibly indicating the loading conducted through the vertebral column closely parallel to those encountered in humans [44, 45]. Histology and microscopic features of monkey IVD also suggest its high similarity to human IVD [45]. Furthermore, microarchitecture of glycosaminoglycans and collagens in the IVD of Rhesus monkey has also been shown to be similar to human IVD at the ultrastructural level [45]. More importantly, recent MRI studies have demonstrated that IVD degeneration develops in healthy monkeys at 5 years of age, the human age equivalent of 17.5 years [45]. With increasing disc degeneration, changes in disc height, MRI signals within NP and hyperostotic spondylotic can all be detected [46]. Such changes are also reported to correlate with radiographic and histopathologic changes [46]. Nonhuman primates, particularly Rhesus monkey, are also considered an advanced model to study IVD degeneration. Therefore, study on cells derived from normal IVD of Rhesus monkey further confirmed the existence of IVD disc progenitor cells (DPCs), which possess clonogenicity, multipotency, and differentiation after serial expansion in vitro and in vivo [47].

Thus, endogenous DPCs have become an enticing subject in the IVD study. However, whether IVD aging/degeneration is associated with or resulted from the diminishing of endogenous DPCs remains unknown. A study has identified a population of NPCs from mice and humans expressing tyrosine kinase receptor Tie 2, a novel surface marker of BMSCs, and disialoganglioside 2 (GD2), a hematopoietic stem cells (HSCs) surface protein [48]. Tie2+GD2+ NPCs are clonally multipotent and generate NP-like tissue in in vivo serial transplantation [48]. Importantly, Tie2+GD2 NPCs are the precursor of Tie2+GD2+ NPCs and the frequency of these progenitor cells decreases with aging and the severity of degeneration of the IVD [48]. Interestingly, DPCs from healthy IVD possess higher differentiation capacity toward chondrogenic lineage and NP-like cells compared with DPCs from degenerative IVD [49]. Therefore, the number and functionality of DPCs are associated with the degenerative process. Further validation of this theory may promote understanding of the etiology of IVD degeneration and contribute to the development of novel biotherapies.

Taking together, DPCs, as an endogenous cell population, may be more suitable in the biotherapeutic treatment of IVD diseases and become a new target for IVD regeneration. However, before any therapeutic application or pre-clinical/clinical trial, several research gaps need to be addressed. First, the mechanism of hypoxia-induced Tie2+ expression on Tie+GD2+ NPCs awaits further elucidation. NPCs were sensitive to oxygen tension and hypoxia-inducible factors (HIF) reduce the susceptibility of hypoxic apoptosis of NPCs. Whether Tie2 couples with HIFs to resist hypoxic stress in NPCs is worthy of being studied. Second, the progenitor niche components of DPCs need to be identified. The fate of DPCs emerges with the pathological change of IVD. This suggests the existence of regulatory components within IVD, modulating the survival and self-renewal of these cells.


4. Conclusions

In conclusion, the studies of DPCs extend the current knowledge regarding the biology of endogenous IVD cells. Combined with tissue engineering and cell therapy, the application of DPCs would pave the way for the manipulation of IVD diseases and provide new hope that may contribute to IVD regeneration.



This work was supported by the Natural Science Foundation of China (81472078).


Declaration of interest

All authors state that they have no conflicts of interest.


  1. 1. Humzah MD, Soames RW. Human intervertebral disc: Structure and function. The Anatomical Record. 1988;220:337-356
  2. 2. Goto S, Uhthoff HK. Notochord action on spinal development. A histologic and morphometric investigation. Acta Orthopaedica Scandinavica. 1986;57:85-90
  3. 3. Kim KW, Lim TH, Kim JG, et al. The origin of chondrocytes in the nucleus pulposus and histologic findings associated with the transition of a notochordal nucleus pulposus to a fibrocartilaginous nucleus pulposus in intact rabbit intervertebral discs. Spine. 2003;28:982-990
  4. 4. Christoph W, Nerlich AG, Schaaf R. Immunohistochemical identification of notochordal markers in cells in the aging human lumbar intervertebral disc. European Spine Journal. 2010;19:1761-1770
  5. 5. Gries NC, Berlemann U, Moore RJ, Vernon-Roberts B. Early histologic changes in lower lumbar discs and facet joints and their correlation. European Spine Journal. 2000;9:23-29
  6. 6. Mercer S, Bogduk N. The ligaments and annulus fibrosus of human adult cervical intervertebral discs. Spine. 1999;24:619-626
  7. 7. Hayes AJ, Benjamin M, Ralphs JR. Role of actin stress fibers in the development of the intervertebral disc: Cytoskeletal control of extracellular matrix assembly. Developmental Dynamics. 1999;215:179-189
  8. 8. Adams MA, Dolan P, McNally DS. The internal mechanical functioning of intervertebral discs and articular cartilage, and its relevance to matrix biology. Matrix Biology. 2009;28:384-389
  9. 9. Mwale F, Roughley P, Antoniou J. Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: A requisite for tissue engineering of intervertebral disc. European Cells & Materials. 2004;8:58-63
  10. 10. Alsalameh S, Amin R, Gemba T, et al. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis & Rheumatology. 2004;50:1522-1532
  11. 11. Phinney DG, Kopen G, Isaacson RL, et al. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth, and differentiation. Journal of Cellular Biochemistry. 1999;72:570-585
  12. 12. Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: Stem cells and their niche. Cell. 2004;116:769-778
  13. 13. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell and Tissue Kinetics. 1970;3:393-403
  14. 14. Taga T, Fukuda S. Role of IL-6 in the neural stem cell differentiation. Clinical Reviews in Allergy & Immunology. 2005;28:249-256
  15. 15. Zouboulis CC, Adjaye J, Akamatsu H, Moe-Behrens G, Niemann C. Human skin stem cells and the ageing process. Experimental Gerontology. 2008;43:986-997
  16. 16. Bodnar MS, Meneses JJ, Rodriguez RT, et al. Propagation and maintenance of undifferentiated human embryonic stem cells. Stem Cells and Development. 2004;13:243-253
  17. 17. Russell KC, Phinney DG, Lacey MR, et al. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem cells. 2010;28:788-798
  18. 18. Park JY, Kuh SU, Park HS, et al. Comparative expression of matrix-associated genes and inflammatory cytokines-associated genes according to disc degeneration: Analysis of living human nucleus pulposus. Journal of Spinal Disorders & Techniques. 2011;24:352-357
  19. 19. Huang S, Tam V, Cheung KM, et al. Stem cell-based approaches for intervertebral disc regeneration. Current Stem Cell Research & Therapy. 2011;6:317-326
  20. 20. Steck E, Bertram H, Abel R, et al. Induction of intervertebral disc-like cells from adult mesenchymal stem cells. Stem Cells. 2005;23:403-411
  21. 21. Sobajima S, Vadala G, Shimer A, et al. Feasibility of a stem cell therapy for intervertebral disc degeneration. The Spine Journal. 2008;8:888-896
  22. 22. McCanless JD, Cole JA, Slack SM, et al. Modeling nucleus pulposus regeneration in vitro: Mesenchymal stem cells, alginate beads, hypoxia, bone morphogenetic protein-2, and synthetic peptide B2A. Spine. 2011;36:2275-2285
  23. 23. Gupta MS, Cooper ES, Nicoll SB. Transforming growth factor-beta 3 stimulates cartilage matrix elaboration by human marrow-derived stromal cells encapsulated in photocrosslinked carboxymethylcellulose hydrogels: Potential for nucleus pulposus replacement. Tissue Engineering Part A. 2011;17:2903-2910
  24. 24. Richardson SM, Hughes N, Hunt JA, et al. Human mesenchymal stem cell differentiation to NP-like cells in chitosan-glycerophosphate hydrogels. Biomaterials. 2008;29:85-93
  25. 25. Yang SH, Wu CC, Shih TT, et al. In vitro study on interaction between human nucleus pulposus cells and mesenchymal stem cells through paracrine stimulation. Spine. 2008;33:1951-1957
  26. 26. Umeda M, Kushida T, Sasai K, et al. Activation of rat nucleus pulposus cells by coculture with whole bone marrow cells collected by the perfusion method. Journal of Orthopaedic Research. 2009;27:222-228
  27. 27. Mwale F, Girard-Lauriault PL, Wang HT, et al. Suppression of genes related to hypertrophy and osteogenesis in committed human mesenchymal stem cells cultured on novel nitrogen-rich plasma polymer coatings. Tissue Engineering. 2006;12:2639-2647
  28. 28. Nelea V, Luo L, Demers CN, Antoniou J, et al. Selective inhibition of type X collagen expression in human mesenchymal stem cell differentiation on polymer substrates surface-modified by glow discharge plasma. Journal of Biomedical Materials Research Part A. 2005;75:216-223
  29. 29. Yang F, Leung VY, Luk KD, et al. Mesenchymal stem cells arrest intervertebral disc degeneration through chondrocytic differentiation and stimulation of endogenous cells. Molecular Therapy. 2009;17:1959-1966
  30. 30. Hee HT, Ismail HD, Lim CT, et al. Effects of implantation of bone marrow mesenchymal stem cells, disc distraction and combined therapy on reversing degeneration of the intervertebral disc. Journal of Bone and Joint Surgery. 2010;92:726-736
  31. 31. Serigano K, Sakai D, Hiyama A, et al. Effect of cell number on mesenchymal stem cell transplantation in a canine disc degeneration model. Journal of Orthopaedic Research. 2010;28:1267-1275
  32. 32. Hiyama A, Mochida J, Iwashina T, et al. Transplantation of mesenchymal stem cells in a canine disc degeneration model. Journal of Orthopaedic Research. 2008;26:589-600
  33. 33. Sakai D, Mochida J, Iwashina T, et al. Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials. 2006;27:335-345
  34. 34. Sakai D, Mochida J, Yamamoto Y, et al. Transplantation of mesenchymal stem cells embedded in Atelocollagen gel to the intervertebral disc: A potential therapeutic model for disc degeneration. Biomaterials. 2003;24:3531-3541
  35. 35. Vadalà G, Sowa G, Hubert M, et al. Mesenchymal stem cells injection in degenerated intervertebral disc: Cell leakage may induce osteophyte formation. Journal of Tissue Engineering and Regenerative Medicine. 2012;6:348-355
  36. 36. Chik TK, Ma XY, Choy TH, Li YY, et al. Photochemically crosslinked collagen annulus plug: A potential solution solving the leakage problem of cell-based therapies for disc degeneration. Acta Biomater. 2013;9:8128-8139
  37. 37. Hiyama A, Skubutyte R, Markova D, et al. Hypoxia activates the notch signaling pathway in cells of the intervertebral disc: Implications in degenerative disc disease. Arthritis & Rheumatology. 2011;63:1355-1364
  38. 38. Risbud MV, Guttapalli A, Tsai TT, et al. Evidence for skeletal progenitor cells in the degenerate human intervertebral disc. Spine. 2007;32:2537-2544
  39. 39. Blanco JF, Graciani IF, Sanchez-Guijo FM, et al. Isolation and characterization of mesenchymal stromal cells from human degenerated nucleus pulposus: Comparison with bone marrow mesenchymal stromal cells from the same subjects. Spine. 2010;35:2259-2265
  40. 40. Feng G, Yang X, Shang H, et al. Multipotential differentiation of human anulus fibrosus cells: An in vitro study. The Journal of Bone and Joint Surgery American. 2010;92:675-685
  41. 41. Brisby H, Papadimitriou N, Brantsing C, et al. The presence of local mesenchymal progenitor cells in human degenerated intervertebral discs and possibilities to influence these in vitro: A descriptive study in humans. Stem Cells and Development. 2013;22:804-814
  42. 42. Erwin WM, Islam D, Eftekarpour E, et al. Intervertebral disc-derived stem cells: Implications for regenerative medicine and neural repair. Spine. 2013;38:211-216
  43. 43. Alini M, Eisenstein SM, Ito K, et al. Are animal models useful for studying human disc disorders/degeneration? European Spine Journal. 2008;17:2-19
  44. 44. Longo UG, Ripalda P, Denaro V, et al. Morphologic comparison of cervical, thoracic, lumbar intervertebral discs of cynomolgus monkey (Macaca fascicularis). European Spine Journal. 2006;15:1845-1851
  45. 45. Kramer PA, Newell-Morris LL, Simkin PA. Spinal degenerative disk disease (DDD) in female macaque monkeys: Epidemiology and comparison with women. Journal of Orthopaedic Research. 2002;20:399-408
  46. 46. Noury F, Mispelter J, Szeremeta F, et al. MRI methodological development of intervertebral disc degeneration: A rabbit in vivo study at 9.4 T. Magnetic Resonance Imaging. 2008;26(10):1421-1432
  47. 47. Huang S, Leung VY, Long D, et al. Coupling of small leucine-rich proteoglycans to hypoxic survival of a progenitor cell-like subpopulation in Rhesus Macaque intervertebral disc. Biomaterials. 2013;34:6548-6558
  48. 48. Sakai D, Nakamura Y, Nakai T, et al. Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc. Nature Communications. 2012;3:1264
  49. 49. Mizrahi O, Sheyn D, Tawackoli W, et al. Nucleus pulposus degeneration alters properties of resident progenitor cells. The Spine Journal. 2013;13;803-814

Written By

Dan Long, Shaoyu Liang, Haiyan Liu, Xiuping Wu, Zhongyang Li, Haozhong Wang, Shishu Huang and Jiancheng Zeng

Submitted: 04 January 2017 Reviewed: 18 April 2017 Published: 29 November 2017